Quantum Genesis AI (QTZM) Net Income towards Common Stockholders (2016 - 2026)
Quantumzyme's Net Income towards Common Stockholders history spans 7 years, with the latest figure at -$4.3 million for Q1 2026.
- For Q1 2026, Net Income towards Common Stockholders fell 14426.13% year-over-year to -$4.3 million; the TTM value through Jan 2026 reached -$4.4 million, down 3525.31%, while the annual FY2025 figure was -$199269.0, 11.59% down from the prior year.
- Net Income towards Common Stockholders reached -$4.3 million in Q1 2026 per QTZM's latest filing, down from -$49868.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$29806.0 in Q1 2025 to a low of -$4.3 million in Q1 2026.
- Average Net Income towards Common Stockholders over 3 years is -$1.1 million, with a median of -$57695.5 recorded in 2024.
- Peak YoY movement for Net Income towards Common Stockholders: rose 23.89% in 2025, then plummeted 14426.13% in 2026.
- A 3-year view of Net Income towards Common Stockholders shows it stood at -$65523.0 in 2024, then grew by 23.89% to -$49868.0 in 2025, then tumbled by 8582.24% to -$4.3 million in 2026.
- Per Business Quant, the three most recent readings for QTZM's Net Income towards Common Stockholders are -$4.3 million (Q1 2026), -$49868.0 (Q4 2025), and -$29806.0 (Q1 2025).